Description

Badges/Icons (below price):

• Purity Verified (HPLC/LC-MS)
• Batch COA Available (QR on vial & page)
• Secure Payments (EMT + Card + Crypto)
• Fast Canada Shipping

Science & Mechanism (accordion section)

How It Works:

Semaglutide is a GLP-1 receptor agonist that slows gastric emptying, enhances insulin secretion, suppresses glucagon, and modulates appetite signals — leading to reduced caloric intake and weight loss.  

Clinical Evidence:

In the STEP-1 Phase III trial, 2.4 mg weekly produced a mean weight reduction of ~14.9% vs. ~2.4% in placebo, sustained at 68 weeks. Higher-dose trials (7.2 mg weekly) demonstrated ~20.7% loss, with 33.2% achieving ≥25% loss, per Novo Nordisk 2025 data.  

💧 Reconstitution & Dosing Tables (Weight Loss Peptides)

Semaglutide (10 mg vial + 2 mL BAC water)

• Final concentration = 5 mg/mL → 50 mcg per unit (0.01 mL) on an insulin syringe.

Dosing Guide (educational)

Titration Schedule (Weekly SubQ):

If tolerability is an issue, maintain a lower dose a week longer before escalating.  

Missed Dose Guidance:

Administer within 5 days of the missed dose; if not possible, skip and resume regular schedule. Maintain ≥48 hours spacing between doses.  

Vial Reconstitution (Sample Protocol)

Assuming 10 mg per vial, reconstitute with 2 mL bacteriostatic water → 1 mg per 0.2 mL syringe volume.

Example:

• 0.25 mg → 0.05 mL (5 units on insulin syringe)
• 2.4 mg → 0.48 mL (48 units on syringe)

Storage & Handling

• Freeze-dry (lyophilized) product must be refrigerated (2–8 °C).
• After reconstitution, store at 4 °C for up to 30 days or −20 °C for longer stability; protect from light.

Disclaimers & Legal Copy

• Content is educational, not personalized medical advice.
• Semaglutide is not FDA/Health Canada approved for cosmetic or optimization use.
• Consult a qualified professional before use.

FAQ Section (toggle list)

• What’s a typical duration of use?
  Many users continue at maintenance dose for 6–12 months or longer, depending on goals.
• Is it safe to combine with other peptides?
  Combining with energy/metabolic peptides like MOTS-c is common—but start one at a time to monitor tolerance.
• How do I read the COA?
  COA shows >99% purity via HPLC and confirmation by MS. Available via QR code on the vial.

Quick Referential Summary Block

📚 Semaglutide — References & Product Page Citations

🔗 Direct References (Medical Papers & Sources)

1. NEJM STEP-1 Trial (RCT, 2.4 mg dose) – 14.9% weight loss
   https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
2. PubMed Abstract (STEP-1 Data)
   https://pubmed.ncbi.nlm.nih.gov/33567185/
3. NEJM Commentary on STEP-1
   https://www.nejm.org/doi/full/10.1056/NEJMe2101705
4. Nature Medicine – Long-term BMI outcomes at 104 weeks
   https://www.nature.com/articles/s41591-024-02996-7
5. Nature Medicine – Two-year effects (STEP-5 Trial)
   https://www.nature.com/articles/s41591-022-02026-4
6. PMC Cohort Study – Real-world outcomes (3 & 6 months)
   https://pmc.ncbi.nlm.nih.gov/articles/PMC9486455/
7. PMC Meta-Analysis of STEP Trials
   https://pmc.ncbi.nlm.nih.gov/articles/PMC10092086/
8. Wikipedia Overview (general, approvals, safety)
   https://en.wikipedia.org/wiki/Semaglutide

✅ Suggested Product Page Citations

• Mean weight loss of 14.9% at 68 weeks with 2.4 mg weekly dosing (STEP-1 trial). NEJM, PubMed
• Sustained reductions after 2 years (STEP-5): ~15.2% mean weight loss. Nature Medicine
• BMI improvements at 104 weeks: 52.4% of participants moved into a lower BMI category. Nature Medicine
• Real-world evidence: ~5.9% loss at 3 months, ~10.9% at 6 months. PMC
• Meta-analysis: Confirms consistent 14.9–17.4% weight loss across STEP trials. PMC